PharmID, Inc. — Form D/A
PharmID, Inc. of SEATTLE, WA, a company, filed a Form D amendment with the SEC on 2020-02-18. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2020-02-18
- Form: D/A
- Accession: 0001719289-20-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Investors: 13
- Date of first sale: 2018-07-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-317795
Issuer
- Name: PharmID, Inc.
- CIK: 0001719289
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 2157 N. NORTHLAKE WAY #240, SEATTLE, WA, 98103
- Phone: 206-992-3589
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Brian Marquardt | Director | Seattle, WA |
| Christopher Swasand | Director | Seattle, WA |
| J. Scott Van Vuren | Director | Seattle, WA |
| Brian Marquardt | Executive Officer | Seattle, WA |
| Tom Pierson | Executive Officer | Seattle, WA |
| J. Scott Van Vuren | Executive Officer | Seattle, WA |
| Scott Van Vuren | Director | Seattle, WA |
| Tim Gibbons | Director | Seattle, WA |
| Tim Gibbons | Executive Officer | Seattle, WA |
Other filings by this issuer (2)
More